Skip to Main Content

A new political action group taking on high drug prices has big plans in the works leading up to November’s midterm elections — and a seven-figure budget to make it happen.

David Mitchell, a cancer patient and the former head of a Washington, D.C., public policy firm, last week unveiled the new organization, called Patients for Affordable Drugs NOW. It’s a separate legal entity operating as the political arm of the advocacy group Patients for Affordable Drugs that Mitchell founded last year. Initial funding comes from an entity financed by the billionaire couple John and Laura Arnold, who’ve spent millions backing other research and advocacy on drug pricing.


While there are plenty of groups in Washington pushing for action on drug pricing, Mitchell’s new organization stands out for its plans to try to boost or sink candidates running for office in the midterms based on their stance and record on drug pricing. Here are a few priorities ahead of the midterms that Mitchell described in a phone call with STAT:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.